APGE - Apogee Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$109.44
DETAILS
HIGH:
$140.00
LOW:
$83.00
MEDIAN:
$103.00
CONSENSUS:
$109.44
UPSIDE:
34.84%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-13 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | SELL | 18,659 | $82.05 | $1.5M |
| 2026-05-13 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | SELL | 1,341 | $82.58 | $111K |
| 2026-05-06 | Dambkowski Carl | officer: Chief Medical Officer | SELL | 1,800 | $84.60 | $152K |
| 2026-05-06 | Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 4,125 | $22.86 | $94K |
| 2026-05-06 | Dambkowski Carl | officer: Chief Medical Officer | SELL | 3,700 | $83.92 | $311K |
| 2026-05-01 | Henderson Jane | officer: Chief Financial Officer | SELL | 811 | $81.02 | $66K |
| 2026-05-01 | Henderson Jane | officer: Chief Financial Officer | SELL | 900 | $82.60 | $74K |
| 2026-05-01 | Henderson Jane | officer: Chief Financial Officer | SELL | 289 | $83.16 | $24K |
| 2026-04-16 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | M-Exempt | 3,000 | $22.86 | $69K |
| 2026-04-16 | Henderson Jane | officer: Chief Financial Officer | SELL | 2,000 | $90.00 | $180K |
| 2026-04-08 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | SELL | 17,800 | $82.48 | $1.5M |
| 2026-04-08 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | SELL | 2,000 | $83.26 | $167K |
| 2026-04-08 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | SELL | 200 | $85.00 | $17K |
| 2026-04-01 | Henderson Jane | officer: Chief Financial Officer | SELL | 1,100 | $85.46 | $94K |
| 2026-04-01 | Henderson Jane | officer: Chief Financial Officer | SELL | 900 | $84.46 | $76K |
| 2026-04-01 | Dambkowski Carl | officer: Chief Medical Officer | SELL | 2,698 | $84.31 | $227K |
| 2026-04-01 | Dambkowski Carl | officer: Chief Medical Officer | SELL | 2,702 | $85.33 | $231K |
| 2026-04-01 | Dambkowski Carl | officer: Chief Medical Officer | SELL | 100 | $85.89 | $9K |
| 2026-04-01 | Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 4,125 | $22.86 | $94K |
| 2026-03-25 | Henderson Jane | officer: Chief Financial Officer | SELL | 2,000 | $85.00 | $170K |
| 2026-03-11 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | SELL | 8,363 | $74.29 | $621K |
| 2026-03-11 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | SELL | 8,219 | $74.83 | $615K |
| 2026-03-11 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | SELL | 3,418 | $75.86 | $259K |
| 2026-03-04 | Dambkowski Carl | officer: Chief Medical Officer | SELL | 3,225 | $70.33 | $227K |
| 2026-03-04 | Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 4,125 | $22.86 | $94K |